Logos Global Management LP Keros Therapeutics, Inc. Transaction History
Logos Global Management LP
- $775 Million
- Q2 2025
A detailed history of Logos Global Management LP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 2,000,000 shares of KROS stock, worth $27.4 Million. This represents 3.45% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 2,000,000
-0.0%
Holding current value
$27.4 Million
Previous $20.4 Million
31.01%
% of portfolio
3.45%
Previous 3.97%
Shares
7 transactions
Others Institutions Holding KROS
# of Institutions
156Shares Held
39.4MCall Options Held
774KPut Options Held
992K-
Adar1 Capital Management, LLC Austin, TX5.39MShares$73.9 Million11.03% of portfolio
-
Madison Avenue Partners, LP New York, NY2.69MShares$36.9 Million3.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.63MShares$36.1 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$35.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$34.5 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $353M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...